PI3K and MAPK pathways mediate the BDNF/TrkB-increased metastasis in neuroblastoma

Abstract

Brain-derived neurotrophic factor (BDNF) and its tyrosine kinase receptor TrkB have been reported to be associated with poor prognosis in neuroblastoma (NB) patients. Our previous studies indicated that BDNF activation of TrkB induces chemo-resistance through activation of phosphoinositide-3-kinase (PI3K)/Akt pathway. In this study, we investigated the role of BDNF/TrkB on metastasis in NB. A tetracycline-regulated TrkB-expressing NB cell line (TB3) was used. Scratch wound healing assay, Boyden chamber migration, and invasion assays were performed to study the migration and invasion of TB3 cells. A tumor xenograft model using SCID-Beige mice was utilized to detect the metastasis of NB tumors in vivo. Inhibitors of PI3K, MAPK, Akt, and mTOR were used. Western blotting was performed to study the expressions of P-Akt, P-Erk, and P-mTOR. Our results showed that in TrkB-expressing NB cells, BDNF treatment significantly increased gap closing (P < 0.01) in scratch wound healing assay, also significantly enhanced the numbers of migrating cells (P < 0.01) and invading cells (P < 0.01) in the Boyden chamber migration and invasion assays. In vivo, NB distant metastases were significantly increased in mice with TrkB-expressing xenograft tumors compared to those with non-TrkB-expressing tumors (P < 0.05). Pre-treatment with any of the inhibitors for PI3K (LY294002), MAPK (PD98059), Akt (perifosine), or mTOR (rapamycin) blocked the BDNF/TrkB-induced increases of cell migration and invasion in TB3 cells, and also blocked the BDNF/TrkB-induced expressions of P-Akt, P-Erk, and P-mTOR. These data indicated that BDNF/TrkB increased metastasis in NB via PI3K/Akt/mTOR and MAPK pathways, and BDNF/TrkB and the downstream targets may be potential targets for the treatment of NB metastasis.Electronic supplementary materialThe online version of this article (doi:10.1007/s13277-016-5433-z) contains supplementary material, which is available to authorized users.

Tropomyosin-Related Kinase Receptor and Neurotrophin Expression in Cutaneous Melanoma Is Associated with a Poor Prognosis and Decreased Survival

“…Furthermore, our observation of a strong association between melanoma metastasis and BDNF immunopositivity is consistent with the report of more frequent expression of BDNF and TrkB in metastatic lesions compared to primary lesions by Innominato et al [22], and further supports the hypothesis that BDNF activation of TrkB receptor signaling promotes neuroblastoma metastasis via PI3K/Akt/mTOR and MAPK pathways [23]. Regarding the mitotic index, we found that a higher index was associated with the presence of TrkA and NGF immunoreactivity.…”

Brain-derived neurotrophic factor (BDNF) -TrKB signaling modulates cancer-endothelial cells interaction and affects the outcomes of triple negative breast cancer

“…Moreover, BDNF has been shown to promote non-small lung cancer proliferation in an autocrine manner and metastasis of neuroblastoma through STAT3 and PI3K and MAPKsingalling pathway, respectively [21, 31]. …”

Copper in the suprachiasmatic circadian clock: A possible link between multiple circadian oscillators

“…We have previously shown that TTM‐induced phase shifts require activation of TrkB receptors, similar to glutamate‐induced phase shifts (Mou et al., ; Yamada & Prosser, ). TrkB is known to activate PI3k/AKT signaling as well as MAPK/ERK signaling (Hua et al., ; Marsden, ; Van't Veer et al., ; Yoshii & Constantine‐Paton, , ; Zhou et al., ). As TTM‐induced phase shifts were not blocked by inhibition of MAPK or NO signaling cascades, we used the PI3K/Akt inhibitor, LY294002, to test whether the PI3K/Akt signaling pathway is involved in TTM‐induced phase shifts (Figure A).…”

“…It is important to reiterate that the effects of Cu, even across physiological (low micromolar) concentrations, appear to vary dramatically across brain regions and cell type (Doreulee et al., ; Shcheglovitov et al., ; Marchetti et al., ; Maureira et al., ; Hu, Ni, Duff‐Canning, & Wang, ; Kapkaeva et al., ). Moreover, while decreases in Cu levels can increase excitotoxicity as mentioned above, higher levels of exogenous Cu can also decrease cell viability through oxidative stress‐linked processes (Hua et al., ; Kapkaeva et al., ). Interestingly, SCN neurons are robustly resistant to glutamate excitotoxicity, and ERK1/2 signaling in SCN tissue has been reported to be neuroprotective against excess glutamate (Bottum, Poon, Haley, Karmarkar, & Tischkau, ; Karmarkar, Bottum, Krager, & Tischkau, ).…”